Publication | Closed Access

Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study

UrologyMedicineSomatostatin AnalogPharmacologyPharmacotherapyCancer TreatmentProstatic DiseaseOncologyLhrh AnalogEndocrine-related CancerHormone-refractory Prostate Cancer